BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Legembre P, Moreau P, Daburon S, Moreau JF, Taupin JL. Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas. Cell Death Differ. 2002;9:329-339. [PMID: 11859415 DOI: 10.1038/sj.cdd.4400960] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Thomas M, Legembre P. Proximity Ligation Assay (PLA) to Evaluate DISC and MISC Composition. Methods Mol Biol 2017;1557:41-8. [PMID: 28078581 DOI: 10.1007/978-1-4939-6780-3_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Saqr HE, Omran OM, Oblinger JL, Yates AJ. TRAIL-induced apoptosis in U-1242 MG glioma cells. J Neuropathol Exp Neurol 2006;65:152-61. [PMID: 16462206 DOI: 10.1097/01.jnen.0000199574.86170.80] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
3 Edmond V, Ghali B, Penna A, Taupin JL, Daburon S, Moreau JF, Legembre P. Precise mapping of the CD95 pre-ligand assembly domain. PLoS One 2012;7:e46236. [PMID: 23049989 DOI: 10.1371/journal.pone.0046236] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
4 Chaigne-delalande B, Mahfouf W, Daburon S, Moreau J, Legembre P. CD95 engagement mediates actin-independent and -dependent apoptotic signals. Cell Death Differ 2009;16:1654-64. [DOI: 10.1038/cdd.2009.111] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
5 Legembre P, Daburon S, Moreau P, Ichas F, de Giorgi F, Moreau JF, Taupin JL. Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment. Mol Cell Biol 2005;25:6811-20. [PMID: 16024813 DOI: 10.1128/MCB.25.15.6811-6820.2005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
6 Chaigne-Delalande B, Guidicelli G, Couzi L, Merville P, Mahfouf W, Bouchet S, Molimard M, Pinson B, Moreau JF, Legembre P. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal. J Immunol 2008;181:7630-8. [PMID: 19017951 DOI: 10.4049/jimmunol.181.11.7630] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
7 Morello A, Daburon S, Castroviejo M, Moreau JF, Dechanet-Merville J, Taupin JL. Enhancing production and cytotoxic activity of polymeric soluble FasL-based chimeric proteins by concomitant expression of soluble FasL. PLoS One 2013;8:e73375. [PMID: 23991192 DOI: 10.1371/journal.pone.0073375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Guidicelli G, Chaigne-Delalande B, Dilhuydy MS, Pinson B, Mahfouf W, Pasquet JM, Mahon FX, Pourquier P, Moreau JF, Legembre P. The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells. PLoS One 2009;4:e5493. [PMID: 19430526 DOI: 10.1371/journal.pone.0005493] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
9 Duffau P, Seneschal J, Nicco C, Richez C, Lazaro E, Douchet I, Bordes C, Viallard J, Goulvestre C, Pellegrin J, Weil B, Moreau J, Batteux F, Blanco P. Platelet CD154 Potentiates Interferon-  Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus. Science Translational Medicine 2010;2:47ra63-47ra63. [DOI: 10.1126/scitranslmed.3001001] [Cited by in Crossref: 131] [Cited by in F6Publishing: 118] [Article Influence: 10.9] [Reference Citation Analysis]
10 Legembre P, Daburon S, Moreau P, Moreau JF, Taupin JL. Modulation of Fas-mediated apoptosis by lipid rafts in T lymphocytes. J Immunol 2006;176:716-20. [PMID: 16393952 DOI: 10.4049/jimmunol.176.2.716] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
11 Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003;10:26-35. [PMID: 12655293 DOI: 10.1038/sj.cdd.4401186] [Cited by in Crossref: 764] [Cited by in F6Publishing: 688] [Article Influence: 40.2] [Reference Citation Analysis]
12 Khadra N, Bresson-Bepoldin L, Penna A, Chaigne-Delalande B, Ségui B, Levade T, Vacher AM, Reiffers J, Ducret T, Moreau JF. CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation. Proc Natl Acad Sci U S A. 2011;108:19072-19077. [PMID: 22065776 DOI: 10.1073/pnas.1116946108] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
13 Miura Y, Koyanagi Y. Death ligand-mediated apoptosis in HIV infection. Rev Med Virol 2005;15:169-78. [PMID: 15765545 DOI: 10.1002/rmv.462] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
14 Daburon S, Devaud C, Costet P, Morello A, Garrigue-Antar L, Maillasson M, Hargous N, Lapaillerie D, Bonneu M, Dechanet-Merville J, Legembre P, Capone M, Moreau JF, Taupin JL. Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activity. PLoS One 2013;8:e54000. [PMID: 23326557 DOI: 10.1371/journal.pone.0054000] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
15 Pizon M, Rampanarivo H, Tauzin S, Chaigne-Delalande B, Daburon S, Castroviejo M, Moreau P, Moreau JF, Legembre P. Actin-independent exclusion of CD95 by PI3K/AKT signalling: implications for apoptosis. Eur J Immunol 2011;41:2368-78. [PMID: 21557211 DOI: 10.1002/eji.201041078] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
16 Tauzin S, Chaigne-Delalande B, Selva E, Khadra N, Daburon S, Contin-Bordes C, Blanco P, Le Seyec J, Ducret T, Counillon L, Moreau JF, Hofman P, Vacher P, Legembre P. The naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathway. PLoS Biol 2011;9:e1001090. [PMID: 21713032 DOI: 10.1371/journal.pbio.1001090] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
17 Hirano K, Sasaki N, Ichimiya T, Miura T, Van Kuppevelt TH, Nishihara S. 3-O-sulfated heparan sulfate recognized by the antibody HS4C3 contributes [corrected] to the differentiation of mouse embryonic stem cells via fas signaling. PLoS One 2012;7:e43440. [PMID: 22916262 DOI: 10.1371/journal.pone.0043440] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
18 Chen LH, Liu XS, Wang WY, Han WN, Pan BR, Jin BQ. Localization of TRAIL/TRAILR in fetal pancreas. World J Gastroenterol 2003; 9(2): 334-337 [PMID: 12532461 DOI: 10.3748/wjg.v9.i2.334] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
19 Poissonnier A, Guégan J, Nguyen HT, Best D, Levoin N, Kozlov G, Gehring K, Pineau R, Jouan F, Morere L, Martin S, Thomas M, Lazaro E, Douchet I, Ducret T, van de Weghe P, Blanco P, Jean M, Vacher P, Legembre P. Disrupting the CD95–PLCγ1 interaction prevents Th17-driven inflammation. Nat Chem Biol 2018;14:1079-89. [DOI: 10.1038/s41589-018-0162-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
20 Laloi M, Perret AM, Chatre L, Melser S, Cantrel C, Vaultier MN, Zachowski A, Bathany K, Schmitter JM, Vallet M, Lessire R, Hartmann MA, Moreau P. Insights into the role of specific lipids in the formation and delivery of lipid microdomains to the plasma membrane of plant cells. Plant Physiol 2007;143:461-72. [PMID: 17114270 DOI: 10.1104/pp.106.091496] [Cited by in Crossref: 126] [Cited by in F6Publishing: 110] [Article Influence: 7.9] [Reference Citation Analysis]
21 Vacher P, Khadra N, Vacher AM, Charles E, Bresson-Bepoldin L, Legembre P. Does calcium contribute to the CD95 signaling pathway? Anticancer Drugs 2011;22:481-7. [PMID: 21317766 DOI: 10.1097/CAD.0b013e32834433ea] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]